Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.59p
   
  • Change Today:
    -0.023p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 5,559,012
  • Market Cap: £21.27m
  • RiskGrade: 340

Regulatory News

Second Price Monitoring Extn 13-Jan-2023 11:05 RNS
Price Monitoring Extension 13-Jan-2023 11:00 RNS
Second Price Monitoring Extn 12-Jan-2023 16:40 RNS
Price Monitoring Extension 12-Jan-2023 16:35 RNS
Second Price Monitoring Extn 12-Jan-2023 14:05 RNS
Price Monitoring Extension 12-Jan-2023 14:00 RNS
Price Monitoring Extension 10-Jan-2023 16:35 RNS
Second Price Monitoring Extn 09-Jan-2023 09:05 RNS
Price Monitoring Extension 09-Jan-2023 09:00 RNS
Second Price Monitoring Extn 05-Jan-2023 16:40 RNS
Price Monitoring Extension 05-Jan-2023 16:35 RNS
Second Price Monitoring Extn 05-Jan-2023 11:05 RNS
Price Monitoring Extension 05-Jan-2023 11:00 RNS
Second Price Monitoring Extn 18-Nov-2022 11:05 RNS
Price Monitoring Extension 18-Nov-2022 11:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.59p
Change Today -0.023p
% Change -1.43 %
52 Week High 3.96
52 Week Low 1.17
Volume 5,559,012
Shares Issued 1,341.82m
Market Cap £21.27m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average
69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average
Price Trend
20.25% below the market average20.25% below the market average20.25% below the market average20.25% below the market average20.25% below the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
16:08 9 @ 1.60p
16:07 491 @ 1.60p
16:06 99,259 @ 1.57p
16:05 100,000 @ 1.57p
16:04 100,000 @ 1.57p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page